FdaApplication
NDA 210326
Identifiers
- fda_app_no: NDA210326
Properties
| Property | Value |
|---|---|
| applicant_name | FRESENIUS KABI USA LLC |
| application_type | NDA |
| approval_date | 2019-05-20 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| FULVESTRANT | FULVESTRANT | 250MG/5ML (50MG/ML) | SOLUTION;INTRAMUSCULAR |
1 product